Physician profile
Jennifer P Stuart
NPI 1629419320
$1,746.30
in general payments reported to CMS, 2019-2025
17 companies · $751 in 2025
The $751 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.80 · 2020: $13.20 · 2021: $53.32 · 2022: $16.38 · 2023: $173 · 2024: $691 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,614.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $298.36 | 2021-2025 | |
| Novo Nordisk INC | $280.85 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $212.49 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $164.53 | 2023-2025 | Airsupra, Farxiga |
| Amgen INC. | $158.56 | 2024-2025 | Evenity, Repatha, Otezla |
| Glaxosmithkline, LLC. | $109.96 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $103.96 | 2022-2025 | |
| Astellas Pharma US INC | $70.66 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $68.77 | 2024-2025 | Cologuard Collection Kit |
| Dynavax Technologies Corporation | $66.97 | 2024-2025 | Heplisav-B |
| Phathom Pharmaceuticals, INC. | $44.52 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $39.93 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Myriad Genetic Laboratories, INC. | $37.13 | 2025 | Prolaris |
| Takeda Pharmaceuticals U.S.A., INC. | $28.83 | 2021 | |
| Currax Pharmaceuticals LLC | $26.71 | 2024-2025 | Contrave, Onzetra Xsail |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $17.25 | 2023 | Apretude |
| Dexcom, INC. | $16.82 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.